文献速递主动脉疾病

半定制开窗支架腔内修复累及弓上血管的非复杂性B型主动脉夹层的初步结果

Initial results of thoracic endovascular repair for uncomplicated type B aortic dissection involving the arch vessels using a semicustom-made thoracic fenestrated stent graft.
PubMed 文献 · J Vasc Surg · 2019-02-18

本回顾性研究纳入24例累及弓上血管的非复杂性B型主动脉夹层患者,分别采用开窗支架(F组13例)或去分支(D组11例)TEVAR。F组手术时间和术后住院时间显著短于D组,两组技术成功率、无主动脉相关死亡及无主要不良事件率无显著差异。开窗支架可能为这类患者提供创伤更小的选择。

要点

  • 开窗支架组手术时间158分钟,显著短于去分支组202分钟(P=.0426)。
  • 开窗支架组术后住院7天,显著短于去分支组22天(P=.0168)。
  • 两组无主动脉相关死亡及逆行性A型夹层,24个月无主要不良事件率无显著差异。

核心结论

  • 开窗支架TEVAR治疗累及弓上血管的非复杂性TBAD初步结果可接受。
  • 开窗支架可能为这类患者提供创伤更小的治疗选择。

研究设计与样本

  • 回顾性研究,2011年8月至2017年7月共24例累及弓上血管的非复杂性TBAD患者。
  • F组13例使用Najuta半定制开窗支架,D组11例采用去分支TEVAR。
  • 主要终点为主动脉相关死亡,次要终点为技术成功和主要不良事件。

主要发现

  • F组与D组技术成功率分别为92.3%和100.0%(P>.99,NS)。
  • F组平均手术时间158分钟,D组202分钟(P=.0426);术后住院分别7天和22天(P=.0168)。
  • 重建分支血管一期通畅率100%,两组均无主动脉相关死亡及逆行性A型夹层。
  • F组1例IA型内漏;D组1例术后卒中,2例因支架诱导的新发破口需二次干预。
  • 中位随访14.1个月(范围1-37),24个月无主要不良事件率F组92.3%、D组72.7%(P=.749,NS)。

关键数值与推荐

  • 技术成功:F组92.3%,D组100.0%(P>.99,NS)。
  • 平均手术时间:F组158分钟,D组202分钟(P=.0426)。
  • 平均术后住院时间:F组7天,D组22天(P=.0168)。
  • 24个月无主要不良事件率:F组92.3%,D组72.7%(P=.749,NS)。
  • 重建分支血管一期通畅率100%,两组无主动脉相关死亡及逆行性A型夹层。

临床怎么用

  • 对累及弓上血管的非复杂性TBAD,开窗支架TEVAR可缩短手术时间和住院时间。
  • 开窗支架可避免弓上血管重建,但需关注IA型内漏风险。
  • 去分支TEVAR需警惕卒中及支架诱导的新发破口需二次干预。

局限性

  • 回顾性研究,样本量小(F组13例,D组11例)。
  • 中位随访仅14.1个月,长期结果未知。
  • 单中心经验,开窗支架为半定制器械,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) for selected type B aortic dissection (TBAD) is a standard treatment; however, TBAD involving the aortic arch is difficult to treat because of the need for arch vessel reconstruction. We report our initial results of TEVAR for uncomplicated TBAD involving the arch vessels using a semicustom-made fenestrated stent graft. METHODS: This is a retrospective study of 24 patients treated by fenestrated (F group) or debranching (D group) TEVAR from August 2011 to July 2017. The patients in the F group received the Najuta semicustom-made fenestrated stent graft (Kawasumi Laboratories, Tokyo, Japan). The fenestrated graft ensures sufficient sealing at the proximal healthy aorta without the need for arch vessel reconstruction. The primary end point was aorta-related mortality; the secondary end points were technical success and major adverse events (stroke, type IA endoleak, retrograde type A aortic dissection, and secondary intervention). RESULTS: During the study period, we treated 65 TBAD cases by TEVAR, including 17 complicated cases. Of the 48 uncomplicated cases, 24 underwent TEVAR with arch vessel involvement (13 in the F group and 11 in the D group). The technical success rates in the F and D groups were 92.3% and 100.0%, respectively (P > .99, NS). The mean operation time was significantly shorter in the F group (158 minutes) than in the D group (202 minutes; P = .0426), and the mean postoperative hospital stay was also significantly shorter in the F group (7 days) than in the D group (22 days; P = .0168). The primary patency rate of the reconstructed branch vessel was 100%, and there were no aorta-related deaths or retrograde type A aortic dissection in either group. One patient had a type IA endoleak in the F group. In the D group, one patient had a postoperative stroke and two patients required secondary interventions for stent graft-induced new entry at the descending aorta. The median follow-up period was 14.1 months (range, 1-37 months). The rate of freedom from aorta-related death was 100% in both groups (P > .99, NS); the rate of freedom from major adverse events at 24 months was 92.3% in the F group and 72.7% in the D group (P = .749, NS). CONCLUSIONS: The initial results of TEVAR with aortic arch vessel reconstruction for uncomplicated TBAD were acceptable. The fenestrated graft may be a less invasive option for the treatment of TBAD involving the aortic arch.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fukushima S, Ohki T, Toya N, et al. Initial results of thoracic endovascular repair for uncomplicated type B aortic dissection involving the arch vessels using a semicustom-made thoracic fenestrated stent graft. J Vasc Surg. 2019. PMID: 30786986. doi:10.1016/j.jvs.2018.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。